EcoDrugPlus

Integrin Beta-3-Like

Ensembl ID : ENSSAUG00010016103
Gene Symbol: LOC115575752
3 Cross references
201 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSSAUG00010022005
Gene Symbol: ITGA4
3 Cross references
225 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSSAUG00010009137
Gene Symbol: ITGA5
3 Cross references
197 Possible Orthologues:

Integrin Subunit Beta 1

Ensembl ID : ENSSAUG00010025771
Gene Symbol: ITGB1
3 Cross references
213 Possible Orthologues:

Integrin Subunit Beta 3

Ensembl ID : ENSSAUG00010018479
Gene Symbol: ITGB3
3 Cross references
194 Possible Orthologues:

Integrin Subunit Beta 5

Ensembl ID : ENSSAUG00010027087
Gene Symbol: ITGB5
3 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 6

Ensembl ID : ENSSAUG00010022014
Gene Symbol: ITGB6
1 Cross references
205 Possible Orthologues:

Integrin Subunit Beta 8

Ensembl ID : ENSSAUG00010000232
Gene Symbol: ITGB8
3 Cross references
202 Possible Orthologues:

Integrin, Alpha V

Ensembl ID : ENSSAUG00010002922
Gene Symbol: ITGAV
1 Cross references
237 Possible Orthologues:

Interleukin 1 Receptor Associated Kinase 4

Ensembl ID : ENSSAUG00010024737
Gene Symbol: IRAK4
3 Cross references
202 Possible Orthologues:

Interleukin-6

Ensembl ID : ENSSAUG00010015916
Gene Symbol: LOC115579128
3 Cross references
162 Possible Orthologues:

Inward Rectifier Potassium Channel 2-Like

Ensembl ID : ENSSAUG00010021069
Gene Symbol: LOC115570991
3 Cross references
207 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).